JPH01275516A - Dandruff-preventive agent and hair-cosmetic - Google Patents
Dandruff-preventive agent and hair-cosmeticInfo
- Publication number
- JPH01275516A JPH01275516A JP10348088A JP10348088A JPH01275516A JP H01275516 A JPH01275516 A JP H01275516A JP 10348088 A JP10348088 A JP 10348088A JP 10348088 A JP10348088 A JP 10348088A JP H01275516 A JPH01275516 A JP H01275516A
- Authority
- JP
- Japan
- Prior art keywords
- dandruff
- hair
- uric acid
- added
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000001840 Dandruff Diseases 0.000 title claims abstract description 86
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 30
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims abstract description 31
- 229940116269 uric acid Drugs 0.000 claims abstract description 31
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims abstract description 28
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 22
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 22
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 22
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract description 22
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000005493 rutin Nutrition 0.000 claims abstract description 22
- 229960004555 rutoside Drugs 0.000 claims abstract description 22
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 abstract description 46
- -1 uric acid glycoside Chemical class 0.000 abstract description 28
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract description 24
- 229960003237 betaine Drugs 0.000 abstract description 12
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 abstract description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 3
- 239000004472 Lysine Substances 0.000 abstract description 3
- 229930182470 glycoside Natural products 0.000 abstract description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 2
- 235000013922 glutamic acid Nutrition 0.000 abstract description 2
- 239000004220 glutamic acid Substances 0.000 abstract description 2
- 150000007968 uric acids Chemical class 0.000 abstract 2
- IYQSDWNYZAHFOV-UHFFFAOYSA-N Homalin Natural products CN1CCCN2CCCCN(CCCN(C)C(Cc3ccccc3)C2=O)C(=O)C1Cc4ccccc4 IYQSDWNYZAHFOV-UHFFFAOYSA-N 0.000 abstract 1
- LNCIXDIFZNXBDP-NSOVKSMOSA-N Homaline Chemical compound C1([C@H]2N(C)CCCN(C(C2)=O)CCCCN2CCCN([C@@H](CC2=O)C=2C=CC=CC=2)C)=CC=CC=C1 LNCIXDIFZNXBDP-NSOVKSMOSA-N 0.000 abstract 1
- 230000002542 deteriorative effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 22
- 239000012071 phase Substances 0.000 description 22
- 235000019441 ethanol Nutrition 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000008213 purified water Substances 0.000 description 17
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 16
- 239000003205 fragrance Substances 0.000 description 16
- 239000000839 emulsion Substances 0.000 description 12
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000002453 shampoo Substances 0.000 description 12
- 235000015961 tonic Nutrition 0.000 description 12
- 230000001256 tonic effect Effects 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 10
- 210000004761 scalp Anatomy 0.000 description 10
- 235000021355 Stearic acid Nutrition 0.000 description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- 239000008117 stearic acid Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000003676 hair preparation Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 4
- 239000004264 Petrolatum Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003899 bactericide agent Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229940055577 oleyl alcohol Drugs 0.000 description 4
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 4
- 229940066842 petrolatum Drugs 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 3
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 3
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- 229940043264 dodecyl sulfate Drugs 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- MFGPUMDDJCTHOI-BKKZJBRMSA-N 3-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,9-dihydropurine-2,6,8-trione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)OC1N1C(=O)NC(=O)C2=C1NC(=O)N2 MFGPUMDDJCTHOI-BKKZJBRMSA-N 0.000 description 2
- ILZWHRVULMLRLY-UHFFFAOYSA-N 7-butyl-3,9-dihydropurine-2,6,8-trione Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2CCCC ILZWHRVULMLRLY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- CJKONRHMUGBAQI-YFKPBYRVSA-N (2s)-2-(trimethylazaniumyl)propanoate Chemical compound [O-]C(=O)[C@H](C)[N+](C)(C)C CJKONRHMUGBAQI-YFKPBYRVSA-N 0.000 description 1
- PYKDRCOQHVRXTE-UHFFFAOYSA-N 1-ethyl-7,9-dihydro-3h-purine-2,6,8-trione Chemical compound O=C1N(CC)C(=O)NC2=C1NC(=O)N2 PYKDRCOQHVRXTE-UHFFFAOYSA-N 0.000 description 1
- ODCYDGXXCHTFIR-UHFFFAOYSA-N 3-Methyluric acid Chemical compound O=C1NC(=O)N(C)C2=C1NC(=O)N2 ODCYDGXXCHTFIR-UHFFFAOYSA-N 0.000 description 1
- ICPDLDAJUABCSP-UHFFFAOYSA-N 3-dodecyl-7,9-dihydropurine-2,6,8-trione Chemical compound O=C1NC(=O)N(CCCCCCCCCCCC)C2=C1NC(=O)N2 ICPDLDAJUABCSP-UHFFFAOYSA-N 0.000 description 1
- JHPNVNIEXXLNTR-UHFFFAOYSA-N 4-(trimethylammonio)butanoate Chemical compound C[N+](C)(C)CCCC([O-])=O JHPNVNIEXXLNTR-UHFFFAOYSA-N 0.000 description 1
- WVLFZLFLLJQWOR-UHFFFAOYSA-N 7,9-dihydro-3h-purine-2,6,8-trione;potassium Chemical compound [K].N1C(=O)NC(=O)C2=C1NC(=O)N2 WVLFZLFLLJQWOR-UHFFFAOYSA-N 0.000 description 1
- QONZYGZXCZVJSJ-UHFFFAOYSA-N 9-dodecyl-3,7-dihydropurine-2,6,8-trione Chemical compound N1C(=O)NC(=O)C2=C1N(CCCCCCCCCCCC)C(=O)N2 QONZYGZXCZVJSJ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- XTFQIRIHLGODFV-NSHDSACASA-N L-phenylalanine betaine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CC=CC=C1 XTFQIRIHLGODFV-NSHDSACASA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 description 1
- FOFYPMPFTYORPL-UHFFFAOYSA-N azanium;2,8-dioxo-7,9-dihydro-3h-purin-6-olate Chemical compound N.N1C(=O)NC(=O)C2=C1NC(=O)N2 FOFYPMPFTYORPL-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229940075285 dandruff control Drugs 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はふけ防止剤及び頭髪化粧料、特にそのふけ抑制
作用を有する物質の改良に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to anti-dandruff agents and hair cosmetics, particularly to the improvement of substances having a dandruff-inhibiting effect.
[従来の技術]
一般に、ふけは皮脂腺の分泌物、汗腺の分泌物、表皮層
の剥離物等からなり、通常は皮脂腺等の分泌亢進により
発生するが、皮膚に細菌や酵母が感染すると、ふけの発
生は病的に助長されるといわれている。このため、従来
から殺菌剤や抗菌剤を添加したふけ防止剤あるいは頭髪
化粧料がふけ防止のために使用されてきた。[Prior Art] Generally, dandruff consists of sebaceous gland secretions, sweat gland secretions, peeled substances from the epidermal layer, etc., and is usually caused by hypersecretion of sebaceous glands, etc., but when the skin is infected with bacteria or yeast, dandruff The occurrence of this disease is said to be promoted pathologically. For this reason, anti-dandruff agents or hair cosmetics to which bactericidal or antibacterial agents have been added have traditionally been used to prevent dandruff.
しかし、殺菌剤や抗菌剤の中には皮膚刺激性等の点で、
人体に対する安全性に問題があるものがあり、また抗菌
剤や殺菌剤を含むふけ防止剤あるいは頭髪化粧料は、連
日の使用により皮膚常在菌の微妙なバランスをくずして
しまうといった、いわゆるエコロジーの観点から、時に
は好ましくない事態を引起こすことが指摘されている。However, some disinfectants and antibacterial agents may cause skin irritation, etc.
There are some products that have safety issues for the human body, and anti-dandruff agents and hair cosmetics that contain antibacterial agents and bactericidal agents have a so-called ecological problem, such as destroying the delicate balance of resident bacteria on the skin when used daily. From this point of view, it has been pointed out that sometimes it causes undesirable situations.
例えば、従来からふけ防止用薬剤として最も効果がある
と認められているジンクピリチオン(ZPT)も抗菌剤
の範晴に含まれるものであり、これを多量に使用するこ
とはできる限り避けることが好ましい゛と考えられてい
る。For example, zinc pyrithione (ZPT), which has traditionally been recognized as the most effective anti-dandruff drug, is also included in the category of antibacterial agents, and it is preferable to avoid using large amounts of it as much as possible. It is believed that.
そこで、かかる抗菌剤や殺菌剤を使用せずにふけの発生
を防止することが広く要望されるにいたり、有効なふけ
抑制作用をもち、しかも抗菌剤や殺菌剤を用いない安全
な物質の探求が行なわれてきた。Therefore, there is a widespread desire to prevent the occurrence of dandruff without the use of such antibacterial agents or bactericides, and the search for safe substances that have effective dandruff control effects and that do not require the use of antibacterial agents or bactericides. has been carried out.
これまで、抗菌性や殺菌性に基づかない、ふけ抑制作用
をもつ物質としては、α−トコフェロール・ビタミンA
酸エステル(特開昭51−73137号公報)やビタミ
ンE・ニコチン酸エステル(ドイツ特許第230158
5号及び第2301660号明細書)が報告されている
。Until now, substances that have anti-dandruff effects that are not based on antibacterial or bactericidal properties include alpha-tocopherol and vitamin A.
acid ester (Japanese Unexamined Patent Publication No. 51-73137) and vitamin E nicotinic acid ester (German Patent No. 230158)
No. 5 and Specification No. 2301660) have been reported.
[発明が解決しようとする課題]
灸來艮歪q皿苅A
しかし、これらビタミンE(すなわち、トコフェロール
)のエステル類は、皮膚上での安定性に欠け、ふけ抑制
の持続的作用は期待できない。[Problems to be solved by the invention] However, these esters of vitamin E (i.e., tocopherol) lack stability on the skin and cannot be expected to have a sustained effect in suppressing dandruff. .
更に、前記のビタミンEのエステル類は水に不溶性であ
るので、剤形によっては油状の沈殿を生じるといった欠
点を有していた。Furthermore, since the vitamin E esters mentioned above are insoluble in water, they have the disadvantage of producing oily precipitates depending on the dosage form.
、また、必要量の前記物質を添加するためには多量の界
面活性剤を必要とするという問題点も有していた。Additionally, there was a problem in that a large amount of surfactant was required to add the required amount of the substance.
光m的
本発明は前記従来技術の問題点に鑑みなされたものであ
り、その目的はふけ防止効果、及び安定性、安全性の点
で優れたふけ防止剤及び頭髪化粧料を提供することにあ
る。The present invention was made in view of the problems of the prior art, and its purpose is to provide an anti-dandruff agent and hair cosmetic that are excellent in terms of anti-dandruff effect, stability, and safety. be.
前記目的を達成するために、本発明者らは広く種々の物
質についてふけ防止作用を調べた結果、尿酸及びその誘
導体、ベタイン類及びそれらの塩、ルチンがふけ防止に
対して極めて有効であり、更に安全性、安定性について
も改善できることを見出し、本発明を完成させるに至っ
た。To achieve the above object, the present inventors investigated the anti-dandruff effects of a wide variety of substances, and found that uric acid and its derivatives, betaines and their salts, and rutin are extremely effective in preventing dandruff. Furthermore, it was discovered that safety and stability could also be improved, and the present invention was completed.
[課題を解決するための手段]
すなわち、請求項1記載の発明は、尿酸及びその誘導体
からなる群より選ばれた一種または二種以上の化合物を
含むことを特徴とするふけ防止剤である。[Means for Solving the Problems] That is, the invention according to claim 1 is an anti-dandruff agent characterized by containing one or more compounds selected from the group consisting of uric acid and derivatives thereof.
請求項2記載の発明は、尿酸及びその誘導体からなる群
より選ばれた一種または二種以上の化合物を含むことを
特徴とする頭髪化粧料である。The invention according to claim 2 is a hair cosmetic composition containing one or more compounds selected from the group consisting of uric acid and its derivatives.
請求項3記載の発明は、ベタイン類及びそれらの塩から
なる群より選ばれた一種または二種以上の化合物を含む
ことを特徴とするふけ防止剤である。The invention according to claim 3 is an anti-dandruff agent characterized by containing one or more compounds selected from the group consisting of betaines and salts thereof.
請求項4記載の発明は、ベタイン類及びそれらの塩から
なる群より選ばれた一種または二種以上の化合物を含む
ことを特徴とする頭髪化粧料である。The invention according to claim 4 is a hair cosmetic composition containing one or more compounds selected from the group consisting of betaines and salts thereof.
請求項5記載の発明は、ルチンを含むことを特徴とする
ふけ防止剤である。The invention according to claim 5 is an anti-dandruff agent characterized by containing rutin.
請求項6記載の発明は、ルチンを含むことを特徴とする
頭髪化粧料である。The invention according to claim 6 is a hair cosmetic containing rutin.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に用いられる尿酸及びその誘導体としては、尿酸
、尿酸ナトリウム、尿酸カリウム、尿酸アンモニウム等
の尿酸またはその塩、3−N−メチル尿酸、3−N−ラ
ウリル尿酸、7−N−ブチル尿酸、1−N−エチル尿酸
、9−N−ラウリル尿酸、3.7−N−ジメチル尿酸な
どの尿酸N−アルキル変性物、3−N−リボシル尿酸、
9−N−グリコジル尿酸などの尿酸配糖体などが挙げら
れる。Examples of uric acid and its derivatives used in the present invention include uric acid, uric acid or its salts such as sodium urate, potassium urate, ammonium urate, 3-N-methyluric acid, 3-N-lauryluric acid, 7-N-butyluric acid, N-alkyl uric acid modified products such as 1-N-ethyluric acid, 9-N-lauryluric acid, 3.7-N-dimethyluric acid, 3-N-ribosyluric acid,
Examples include uric acid glycosides such as 9-N-glycodyluric acid.
これらの尿酸及びその塩や尿酸配糖体は血清中にも見出
されており、哺乳類の平均生存年齢と血清中尿酸濃度と
の関連や、癌の発生率と血清尿酸値との関連より最近注
目されている物質であるが、ふけ防止剤あるいは頭髪化
粧料としての適用例は現在のところ見当らない。These uric acid, its salts, and uric acid glycosides are also found in serum, and recently the relationship between the average survival age of mammals and serum uric acid concentration, and the relationship between cancer incidence and serum uric acid level have been studied. Although this substance is attracting attention, there are currently no examples of its application as an anti-dandruff agent or hair cosmetic.
かかる尿酸及びその誘導体のふけ防止剤あるいは頭髪化
粧料への配合量は、全量に対してとくに限定されないが
、通常配合量は、0.001重量%〜0.5重量%であ
る。The amount of uric acid and its derivatives added to the anti-dandruff agent or hair cosmetic is not particularly limited, but the amount is usually 0.001% to 0.5% by weight.
0.001重量%未満ではふけ防止効果が乏しくなる傾
向があり、逆に0. 5重量%をこえて配合しても効果
の大きな増加は望めない。If it is less than 0.001% by weight, the anti-dandruff effect tends to be poor; Even if the amount exceeds 5% by weight, no significant increase in effectiveness can be expected.
本発明に用いられるベタイン類としては、リジンベタイ
ン、オルニチンベタイン、ホマリン、トリゴネリン、ア
ラニンベタイン、タウロベタイン、カルニチン、スタキ
ドリン、グルタミン酸ベタイン、フェニルアラニンベタ
イン、γ−ブチロベタイン、ベタインなどが挙げられる
。Examples of the betaines used in the present invention include lysine betaine, ornithine betaine, homarin, trigonelline, alanine betaine, taurobetaine, carnitine, stachydrine, glutamic acid betaine, phenylalanine betaine, γ-butyrobetaine, betaine, and the like.
これらのベタイン類またはその塩は海藻中や魚類、甲殻
類に見出されているが、その生理学上の存在意義は必ず
しも明らかになっておらず、ふけ防止剤あるいは頭髪化
粧料としての適用例は現在のところ見当らない。These betaines or their salts are found in seaweed, fish, and crustaceans, but their physiological significance is not necessarily clear, and there are no examples of their use as anti-dandruff agents or hair cosmetics. Not found at the moment.
かかるベタイン類及びそれらの塩のふけ防止剤あるいは
頭髪化粧料への配合量は、全量に対してとくに限定され
ないが、通常は、0.001〜5重量%である。The amount of betaines and their salts added to the anti-dandruff agent or hair cosmetic is not particularly limited, but is usually 0.001 to 5% by weight based on the total amount.
0.001重量%未満ではふけ防止効果が乏しくなる傾
向があり、逆に5重量%をこえて配合しても効果の大き
な増加は望めない。If it is less than 0.001% by weight, the anti-dandruff effect tends to be poor, and conversely, if it is added in excess of 5% by weight, no significant increase in the effect can be expected.
ルチンを むふけ 止作ないしリ 5 主・本発明で用
いられるルチンは植物(エンジュのつぼみ、ソバの全草
)から抽出して得られるもので、血管補強・脳溢血予防
剤として用いられている経口投与の医薬品である。その
薬効としては、毛細血管の脆弱性及び異常な透過性を回
復させることが報告されている。又、ヒアルロニダーゼ
阻害作用も知られている。5 Main Rutin used in the present invention is obtained by extracting from plants (Japanese apricot buds, whole buckwheat plants), and is an oral drug used as a blood vessel reinforcement and cerebral hemorrhage prevention agent. It is a drug for administration. As for its medicinal effects, it has been reported that it restores the fragility and abnormal permeability of capillaries. It is also known to inhibit hyaluronidase.
本発明におけるルチンのふけ防止剤あるいは頭髪化粧料
への配合量は、全量に対してとくに限定されないが、通
常は、0.000001〜5重量%である。The amount of rutin added to the anti-dandruff agent or hair cosmetic in the present invention is not particularly limited, but is usually 0.000001 to 5% by weight based on the total amount.
0.000001重量%未満ではふけ防止効果が乏しく
なる傾向があり、逆に5重量%をこえて配合しても効果
の大きな増加は望めない。If it is less than 0.000001% by weight, the anti-dandruff effect tends to be poor, and conversely, if it is added in excess of 5% by weight, no significant increase in the effect can be expected.
本発明の尿酸及びその誘導体、あるいはベタイン類およ
びそれらの塩は水に易溶で、油脂や有機性溶媒には不溶
または溶けにくい物質であるが、懸濁状態でもふけ防止
剤ないし頭髪化粧料への配合は可能であり、効果に対し
て何の影響も与えない。Uric acid and its derivatives, or betaines and their salts of the present invention are easily soluble in water and insoluble or hardly soluble in oils and fats and organic solvents, but even in a suspended state they can be used as anti-dandruff agents or hair cosmetics. is possible and does not have any effect on the effectiveness.
又、ルチンも、水やアルコール等の極性溶媒に易溶な物
質であるが、懸濁状態でもふけ防止剤ないし頭髪化粧料
への配合は可能であり、効果に対して何の影響も与えな
い。Rutin is also a substance that is easily soluble in polar solvents such as water and alcohol, but even in a suspended state it can be incorporated into anti-dandruff agents or hair cosmetics without any effect on the effectiveness. .
なお、本発明において、ふけ防止剤は、医薬品、医薬部
外品、化粧品とすることが好適である。In the present invention, the anti-dandruff agent is preferably used as a pharmaceutical, a quasi-drug, or a cosmetic.
又、本発明における頭髪化粧料(薬用化粧料、すなわち
医薬部外品をも含む)は、頭皮ないし頭髪に使用するも
のを広く指し、例えば、ヘアトニック、頭皮用乳液、ヘ
アリキッド、ヘアシャンプー、ヘアリンス、ヘアクリー
ム、ヘアスプレー等が含まれる。Furthermore, hair cosmetics (including medicinal cosmetics, that is, quasi-drugs) in the present invention broadly refer to those used for the scalp or hair, such as hair tonics, scalp emulsions, hair liquids, hair shampoos, Includes hair rinse, hair cream, hair spray, etc.
さらに、本発明のふけ防止剤あるいは頭髪化粧料には、
前記必須成分の他、一般の医薬品、医薬部外品、化粧品
に配合される通常の成分、例えば、油性成分、紫外線吸
収剤、防腐剤、保湿剤、界面活性剤、香料、水、アルコ
ール、増粘剤、色剤、薬剤等を配合することができる。Furthermore, the anti-dandruff agent or hair cosmetic of the present invention includes:
In addition to the above-mentioned essential ingredients, there are other ingredients commonly used in general medicines, quasi-drugs, and cosmetics, such as oily ingredients, ultraviolet absorbers, preservatives, humectants, surfactants, fragrances, water, alcohol, and additives. A sticky agent, a coloring agent, a drug, etc. can be added.
また、尿酸及びその誘導体、ベタイン類及びそれらの塩
あるいはルチンを併せ配合することも可能である。It is also possible to combine uric acid and its derivatives, betaines and their salts, or rutin.
[作用]
本発明によるふけ防止剤及び頭髪化粧料が有効なふけ防
止作用を示す機構は、頭皮組織内の代謝反応が適度に調
整されるとともに、ふけの発生要因である過酸化脂質の
頭皮上での形成を尿酸及びその誘導体、ベタイン類及び
それらの塩あるいはルチンが阻害するためと考えられる
。[Action] The mechanism by which the anti-dandruff agent and hair cosmetic according to the present invention exhibits an effective anti-dandruff effect is that metabolic reactions within the scalp tissue are appropriately adjusted, and lipid peroxide, which is a factor in the occurrence of dandruff, is reduced on the scalp. This is thought to be due to the fact that uric acid and its derivatives, betaines and their salts, or rutin inhibit their formation.
[実施例] 次に実施例により本発明を更に詳細に説明する。[Example] Next, the present invention will be explained in more detail with reference to Examples.
なお、本発明はこれによって限定されるものではない。Note that the present invention is not limited to this.
また、配合量は重量%で示している。Moreover, the blending amount is shown in weight%.
およびその− の
まず、尿酸及びその誘導体のふけ防止に対する効果を調
べるため、次の様な試験を行なった。First, the following tests were conducted to examine the effects of uric acid and its derivatives on preventing dandruff.
夾族且1
尿酸0.001重量%を、ヘアシャンプーに配合してふ
け抑制効果を測定した。EXAMPLE 1 0.001% by weight of uric acid was added to a hair shampoo and the dandruff suppressing effect was measured.
すなわち、精製水79.999gに、ラウリル硫酸トリ
エタノールアミン15g1ヤシ油脂肪酸ジエタノールア
マイド5g1尿酸0.001g及び香料・色素を適量、
順次添加し、加熱後冷却してヘアシャンプーを得た。That is, to 79.999 g of purified water, 15 g of lauryl sulfate triethanolamine, 5 g of coconut oil fatty acid diethanolamide, 0.001 g of uric acid, and appropriate amounts of fragrances and pigments.
The ingredients were sequentially added, heated, and then cooled to obtain a hair shampoo.
ふけ防止効果の測定は次の様にして行なった。The anti-dandruff effect was measured as follows.
対象者として28〜42才で、ふけの比較的多い男性7
名を選び、テストを行なった。The target audience is men between the ages of 28 and 42 who have a relatively large amount of dandruff7.
I chose a name and did a test.
試験開始前に尿酸類無添加のシャンプーで洗髪し、洗髪
後2日間に累積したふけを採取し、採取したふけ中の蛋
白質量を測定した(コントロール期)。Before the start of the test, the hair was washed with a uric acid-free shampoo, and the accumulated dandruff was collected for two days after the hair washing, and the amount of protein in the collected dandruff was measured (control period).
次いで、尿酸を添加したシャンプーを1力月使用させ、
その間、コントロール期と同様にふけを採取し蛋白質量
を測定した(試料期)。Next, use a shampoo containing uric acid for one month.
During this period, dandruff was collected and the amount of protein was measured in the same manner as in the control period (sample period).
コントロール期の1力月間の平均ふけ蛋白質量と試料期
の後半2週間の平均ふけ蛋白量とを比較し、ふけの減少
率が
50%以上であった場合 ・・・ A30%以上
、50%未満の場合 ・・・ B20%以上、30%未
満の場合 ・・・ 020%未満の場合
・・・ Dとランク付けをした。Compare the average dandruff protein amount for one month of the control period with the average dandruff protein amount for the last two weeks of the sample period, and if the reduction rate of dandruff is 50% or more... A: 30% or more, less than 50% In the case of... B20% or more but less than 30%...0020% or more
...I ranked it D.
この結果を次の第1表に示す。The results are shown in Table 1 below.
この結果、尿酸を配合したものは優れたふけ防止効果を
有することが認められた。As a result, it was found that products containing uric acid had excellent anti-dandruff effects.
第1表
以下にその他の実施例を示す。いずれも前記同様の使用
試験の結果、ふけ防止に優れた効果を示した。Other examples are shown in Table 1 and below. All of them showed excellent effectiveness in preventing dandruff as a result of use tests similar to those described above.
夾族孤l へアシャンプー
次の配合組成よりなるヘアシャンプーを調製した。製造
法は前記第1実施例に準じる。。Hair shampoo A hair shampoo having the following composition was prepared. The manufacturing method is similar to that of the first embodiment. .
ラウリルサルフェート・Na 5. 0ラウ
リルサルフエート
トリエタノールアミン 5.0ラウリルジメ
チルアミノ酢酸ベタイン 6.0エチレングリコール脂
肪酸エステル 2.0ポリエチレングリコール
5.03−N−ラウリル尿酸
0.05香料 0・
3水 残余
大鑑1 ヘアリンス
次の配合組成よりなるヘアリンスを調製した。Lauryl sulfate/Na 5. 0 Lauryl sulfate triethanolamine 5.0 Lauryl dimethylaminoacetic acid betaine 6.0 Ethylene glycol fatty acid ester 2.0 Polyethylene glycol
5.03-N-lauryl uric acid
0.05 Fragrance 0・
3 Water Residual Guide 1 Hair Rinse A hair rinse with the following composition was prepared.
製造法は常法によった。The manufacturing method was a conventional method.
ジプロピレングリコール 4.0ステアリ
ルトリメチル
アンモニウムクロライド 2.0ステアリルア
ルコール 1.0ポリオキシエチレン(
60モル付加)
硬化ヒマシ油 0.5グリセリンス
テアリン酸エステル 0.59−N−ラウリル尿酸
0,02水 残余
夾族週A ヘアトニック
エチルアルコール55gにポリオキシエチレン(8モル
付加)オレイルアルコールエーテル2g及び7−N−ブ
チル尿酸0.Olg、香料を適量加え、室温下に溶解さ
せてアルコール相を得た。Dipropylene glycol 4.0 Stearyltrimethylammonium chloride 2.0 Stearyl alcohol 1.0 Polyoxyethylene (
Hydrogenated castor oil 0.5 Glycerin stearate 0.59-N-Lauryl uric acid 0.02 Water Residual group A Hair tonic ethyl alcohol 55g polyoxyethylene (8 mole addition) oleyl alcohol ether 2g and 7-N-butyluric acid 0. Appropriate amounts of Olg and fragrance were added and dissolved at room temperature to obtain an alcohol phase.
別に精製水37.99gにグリセリン5gを加えて溶解
させた。冷却後、色素を適量加え、この水相部にアルコ
ール相を加えて可溶化してふけ防止効果のあるヘアトニ
ックを得た。Separately, 5 g of glycerin was added and dissolved in 37.99 g of purified water. After cooling, an appropriate amount of the dye was added, and an alcohol phase was added to the aqueous phase to solubilize it to obtain a hair tonic with an anti-dandruff effect.
犬施透五 ヘアシャンプー
エチルアルコール52.5gにポリオキシプロピレンブ
チルエーテル20g、スクワラン2g13.7−ジメチ
ル尿酸0.005g及び香料を適量加え室温下に溶解さ
せたアルコール相に、精製水25.495gに色素を適
量加えた分を添加し攪拌して、ふけ抑制効果のあるヘア
リキッドを得た。Tougo Inuse Hair Shampoo 52.5 g of ethyl alcohol, 20 g of polyoxypropylene butyl ether, 2 g of squalane, 13.7-dimethyluric acid 0.005 g, and an appropriate amount of fragrance were dissolved at room temperature.The alcohol phase was dissolved at room temperature, and the pigment was added to 25.495 g of purified water. A suitable amount of the above was added and stirred to obtain a hair liquid with a dandruff suppressing effect.
実11阻美−頭皮用乳液 ステアリン酸2g1セチルアルコール1.5g。Real 11 Enbi - Scalp emulsion 2g stearic acid 1.5g cetyl alcohol.
ワセリン3g1流動パラフイン12g1ポリオキシエチ
レン(10モル付加)モノオレイン酸エステル2g1尿
酸ナトリウムO0Ig、及び香料適量を混合し80℃に
加熱し油相を得た。別にプロピレングリコール5g1
トリエタノールアミン1g1及び精製水73.4gを8
0℃に加熱して、前記油相部を攪拌しながら徐々に加え
、冷却してふけ防止効果のある頭皮用乳液を得た。3 g of vaseline, 12 g of liquid paraffin, 2 g of polyoxyethylene (10 mol addition), monooleate ester, 1 g of sodium urate, and an appropriate amount of perfume were mixed and heated to 80° C. to obtain an oil phase. Separately, propylene glycol 5g1
1 g of triethanolamine and 73.4 g of purified water
The mixture was heated to 0° C., the oil phase was gradually added while stirring, and the mixture was cooled to obtain a scalp emulsion having an anti-dandruff effect.
夾旙孤ユ ヘアクリーム
ステアリン酸2g1ステアリルアルコール7g1オクチ
ルドデカノール6g1ポリオキシエチレン(10モル付
加)セチルエーテル3g、3−N−リボシル尿酸0.2
g及び香料を適量加えて80℃に加熱して油相を得た。Hair Cream Stearic acid 2g1 Stearyl alcohol 7g1 Octyldodecanol 6g1 Polyoxyethylene (10 mole addition) Cetyl ether 3g, 3-N-ribosyluric acid 0.2
g and fragrance were added thereto and heated to 80°C to obtain an oil phase.
別にプロピレングリコール5g、及び精製水76.8g
を80℃に加熱し、この水相に前記油相部を攪拌しつつ
徐々に加え、冷却してふけ抑制効果のあるヘアクリーム
を得た。Separately, 5g of propylene glycol and 76.8g of purified water
was heated to 80° C., the oil phase was gradually added to the aqueous phase with stirring, and the mixture was cooled to obtain a hair cream having a dandruff suppressing effect.
犬り週1 頭髪用乳液 ポリエチレングリコール1500 3.5g。Inuri week 1 Hair emulsion Polyethylene glycol 1500 3.5g.
トリエタノールアミン1gを精製水74.999gに加
温溶解し70℃に保った。ステアリン酸2゜5g、セチ
ルアルコール1.5g、ワセリン5g。1 g of triethanolamine was dissolved in 74.999 g of purified water by heating and maintained at 70°C. Stearic acid 2.5g, cetyl alcohol 1.5g, petrolatum 5g.
スタフ9210g1ポリオキシエチレン(10モル付加
)モノオレイン酸エステル2g1尿酸0゜001gを加
温溶解し、70℃に保ち水相部に加えた。予備乳化後、
ホモミキサーで均一に乳化し徐冷してふけ防止効果のあ
る頭髪用乳液を調製した。Stuff 9210 g 1 polyoxyethylene (10 moles added) 2 g monooleate 1 0.001 g uric acid were dissolved by heating, and the mixture was kept at 70° C. and added to the aqueous phase. After pre-emulsification,
A hair emulsion with an anti-dandruff effect was prepared by uniformly emulsifying the product using a homomixer and slowly cooling it.
ベタイン びそれらの塩の
まず、ベタイン類及びそれらの塩のふけ防止に対する効
果を調べるため、次の様な試験を行なった。Betaines and Their Salts First, the following tests were conducted to examine the effects of betaines and their salts on preventing dandruff.
火嵐ガ1
ベタイン類としてホマリン0.02重量%を、ヘアトニ
ックに配合してふけ抑制効果を測定した。Fire Arashi Ga 1 0.02% by weight of Homarin as a betaine was added to a hair tonic and the dandruff suppressing effect was measured.
すなわち、エチルアルコール55gにポリオキシエチレ
ン(8モル付加)オレイルアルコールエーテル2g及び
ホマリン0.02g、香料を適量加え、室温下に溶解さ
せてアルコール相を得た。That is, 2 g of polyoxyethylene (8 mol addition) oleyl alcohol ether, 0.02 g of homarin, and an appropriate amount of fragrance were added to 55 g of ethyl alcohol, and the mixture was dissolved at room temperature to obtain an alcohol phase.
別に精製水37.98gにグリセリン5gを加えて溶解
させた。冷却後色素を適量加え、この水相部にアルコー
ル相を加えて可溶化してヘアトニックを得た。Separately, 5 g of glycerin was added and dissolved in 37.98 g of purified water. After cooling, an appropriate amount of the dye was added, and an alcohol phase was added to the aqueous phase to solubilize it to obtain a hair tonic.
ふけ防止効果の測定は次の様にして行なった。The anti-dandruff effect was measured as follows.
対象者として28〜42才で、ふけの比較的多い男性7
名を選び、テストを行なった。The target audience is men between the ages of 28 and 42 who have a relatively large amount of dandruff7.
I chose a name and did a test.
試験開始前にベタイン類無添加のシャンプーで洗髪し、
洗髪後2日間にわたり朝夕2回ペタイン類抜去のヘアト
ニックを使用し累積したふけを採取し、採取したふけ中
の蛋白質量を測定した(コントロール期)。Before starting the test, wash your hair with a betaine-free shampoo.
After hair washing, accumulated dandruff was collected using a hair tonic without petaine twice in the morning and evening for two days, and the amount of protein in the collected dandruff was measured (control period).
次いで、ホマリンを添加したヘアトニックを1力月間使
用させ、その間、コントロール期と同様にふけを採取し
蛋白質量を測定した(試料期)。Next, a hair tonic containing homarin was used for one month, during which time dandruff was collected and the amount of protein was measured in the same manner as in the control period (sample period).
評価法は尿酸を使用した前記実施例1に準じる。The evaluation method is based on the above Example 1 using uric acid.
評価結果を次の第2表に示す。The evaluation results are shown in Table 2 below.
この結果、ホマリンを配合したものは優れたふけ防止効
果を有することが認められた。As a result, it was found that products containing homarin had excellent anti-dandruff effects.
(以下余白)
第2表
以下にその他の実施例を示す。いずれも前記同様の使用
試験の結果、ふけ防止に優れた効果を示した。(The following is a margin) Other examples are shown in Table 2 and below. All of them showed excellent effectiveness in preventing dandruff as a result of use tests similar to those described above.
尖血孤1没 へアシヤンブ−
次の配合組成よりなるヘアシャンプーを調製した。製造
法は前記第1実施例に準じる。A hair shampoo having the following composition was prepared. The manufacturing method is similar to that of the first embodiment.
ラウリルサルフェート・Na 5、Oラウリ
ルサルフェート
トリエタノールアミン 5.0ラウリルジメ
チルアミノ酢酸ベタイン 6.0エチレングリコール脂
肪酸エステル 2.0ポリエチレングリコール
5.0トリゴネリン
0.03香料 0.
3水 残余
火嵐拠1ユ ヘアリンス
次の配合組成よりなるヘアリンスを調製した。Lauryl sulfate/Na 5,0 Lauryl sulfate triethanolamine 5.0 Lauryl dimethylaminoacetic acid betaine 6.0 Ethylene glycol fatty acid ester 2.0 Polyethylene glycol
5.0 trigonelline
0.03 Fragrance 0.
3 Water Residual Fire Storm Base 1 Yu Hair Rinse A hair rinse having the following composition was prepared.
製造法は常法によった。The manufacturing method was a conventional method.
ジプロピレングリコール 4.0ステアリ
ルトリメチル
アンモニウムクロライド 2.0ステアリルア
ルコール 1. 0ポリオキシエチレン
(60モル付加)
硬化ヒマシ油 0. 5グリセリン
ステアリン酸エステル 0.5タウロベタイン
0,5水 残余
火皿器1ス ヘアトニック
エチルアルコール55gにポリオキシエチレン(8モル
付加)オレイルアルコールエーテル2g及びリジンベタ
イン0.2g、香料を適量加え、室温下に溶解させてア
ルコール相を得た。別に精製水37.8gにグリセリン
5gを加えて溶解させた。冷却後、色素を適量加え、こ
の水相部にアルコール相を加えて可溶化してふけ防止効
果のあるヘアトニックを得た。Dipropylene glycol 4.0 Stearyltrimethylammonium chloride 2.0 Stearyl alcohol 1. 0 Polyoxyethylene (60 mol addition) Hydrogenated castor oil 0. 5 Glycerin stearate 0.5 Taurobetaine
0.5 water 1 s. hair tonic ethyl alcohol 2 g of polyoxyethylene (8 moles added) oleyl alcohol ether, 0.2 g of lysine betaine, and an appropriate amount of fragrance were added and dissolved at room temperature to obtain an alcohol phase. . Separately, 5 g of glycerin was added and dissolved in 37.8 g of purified water. After cooling, an appropriate amount of the dye was added, and an alcohol phase was added to the aqueous phase to solubilize it to obtain a hair tonic with an anti-dandruff effect.
犬皿週11 ヘアリキッド
エチルアルコール52.5gにポリオキシプロピレンブ
チルエーテル20g、スクワラン2g1オルニチンベタ
イン0.05g及び香料を適量加え室温下に溶解させた
アルコール相に、精製水25.45gに色素を適量加え
た分を添加し攪拌して、ふけ抑制効果のあるヘアリキッ
ドを得た。Dog plate week 11 Hair liquid Add 20 g of polyoxypropylene butyl ether, 2 g of squalane, 0.05 g of ornithine betaine, and an appropriate amount of fragrance to 52.5 g of hair liquid ethyl alcohol, dissolve at room temperature, and add an appropriate amount of coloring matter to 25.45 g of purified water. A hair liquid having a dandruff suppressing effect was obtained by adding the following ingredients and stirring.
夾五珂11 頭皮用乳液 ステアリン酸2g1セチルアルコール1.5g。Kwagoka 11 Scalp emulsion 2g stearic acid 1.5g cetyl alcohol.
ワセリン3g1流動パラフィン12g1ポリオキシエチ
レン(10モル付加)モノオレイン酸エステル2g17
−プチロベタイン0.08g、及び香料適量を混合し8
0℃に加熱し油相を得た。別にプロピレングリコール5
g1 トリエタノールアミンIg、及び精製水73.4
2gを80℃に加熱して、前記油相部を攪拌しながら徐
々に加え、冷却してふけ防止効果のある頭皮用乳液を得
た。Vaseline 3g1 Liquid paraffin 12g1 Polyoxyethylene (10 mole addition) monooleate ester 2g17
- Mix 0.08 g of petitrobetaine and an appropriate amount of fragrance.
It was heated to 0°C to obtain an oil phase. Separately, propylene glycol 5
g1 Triethanolamine Ig and purified water 73.4
2 g was heated to 80° C., the oil phase was gradually added while stirring, and the mixture was cooled to obtain a scalp milky lotion having an anti-dandruff effect.
χ皿拠1j へアクリーム
ステアリン酸2g1ステアリルアルコール7g1オクチ
ルドデカノール6g1ポリオキシエチレン(10モル付
加)セチルエーテル3g1カルニチン0.05g及び香
料を適量加えて80℃に加熱して油相を得た。別にプロ
ピレングリコール5g1及び精製水76.95gを80
℃に加熱し、この水相に前記油相部を攪拌しつつ徐々に
加え、冷却してふけ抑制効果のあるヘアクリームを得た
。χ Plate 1j Hair Cream Stearic acid 2g1 Stearyl alcohol 7g1 Octyldodecanol 6g1 Polyoxyethylene (10 mol addition) Cetyl ether 3g1 Carnitine 0.05g and an appropriate amount of fragrance were added and heated to 80°C to obtain an oil phase. Separately, add 5 g of propylene glycol and 76.95 g of purified water to 80 g.
The oil phase was gradually added to the aqueous phase while stirring, and the mixture was cooled to obtain a hair cream having a dandruff suppressing effect.
実1111」−頭髪用乳液 ポリエチレングリコール1500 3.5g。Mi 1111” - hair emulsion Polyethylene glycol 1500 3.5g.
トリエタノールアミン1gを精製水74.49gに加温
溶解し70℃に保った。ステアリン酸2゜5g、セチル
アルコール1.5g、ワセリン5g。1 g of triethanolamine was dissolved in 74.49 g of purified water by heating and maintained at 70°C. Stearic acid 2.5g, cetyl alcohol 1.5g, petrolatum 5g.
スタフ9210g1ポリオキシエチレン(10モル付加
)モノオレイン酸エステル2g1スタキドリン0.Ol
gを加温溶解し、70℃に保ち水相部に加えた。予備乳
化後、ホモミキサーで均一に乳化し徐冷してふけ防止効
果のある頭髪用乳液を調製した。Stuff 9210g 1 polyoxyethylene (10 mol addition) monooleic acid ester 2g 1 Stachydrine 0. Ol
g was dissolved by heating and added to the aqueous phase while keeping the temperature at 70°C. After preliminary emulsification, the mixture was uniformly emulsified using a homomixer and slowly cooled to prepare a hair emulsion with anti-dandruff effect.
庚±2曵使」
まず、ルチンのふけ防止に対する効果を調べるため、次
の様な試験を行なった。First, in order to investigate the effect of rutin on preventing dandruff, the following test was conducted.
笈嵐週上ニ
ルチン0,0002重量%を、ヘアトニックに配合して
ふけ抑制効果を測定した。0,0002% by weight of Oran Weekjo Niltin was blended into a hair tonic and the dandruff suppressing effect was measured.
なお、ヘアトニックの調製及びふけ防止効果の測定法は
前記実施例9に準じる。The method for preparing the hair tonic and measuring the anti-dandruff effect was in accordance with Example 9 above.
評価結果を次の第3表に示す。The evaluation results are shown in Table 3 below.
この結果、ルチンを配合したものは優れたふけ防止効果
を有することが認められた。As a result, it was found that products containing rutin had excellent anti-dandruff effects.
(以下余白)
第3表
以下にその他の実施例を示す。いずれも前記同様の使用
試験の結果、ふけ防止に優れた効果を示した。(The following is a margin) Other examples are shown in Table 3 and below. All of them showed excellent effectiveness in preventing dandruff as a result of use tests similar to those described above.
火皿ガ11 へアシャンプー
次の配合組成よりなるヘアシャンプーを調製した。製造
法は前記第1実施例に準じる。Hi-Saraga 11 Hair Shampoo A hair shampoo having the following composition was prepared. The manufacturing method is similar to that of the first embodiment.
ラウリルサルフェート・Na 5,0ラウリ
ルサルフエート
トリエタノールアミン 5.0ラウリルジメ
チルアミノ酢酸ベタイン 6.0エチレングリコール脂
肪酸エステル 2.0ポリエチレングリコール
5.0ルチン 0
.003香料 0.3
水 残余
夾族皿11 ヘアリンス
次の配合組成よりなるヘアリンスを調製した。Lauryl sulfate/Na 5.0 Lauryl sulfate triethanolamine 5.0 Lauryl dimethylaminoacetic acid betaine 6.0 Ethylene glycol fatty acid ester 2.0 Polyethylene glycol
5.0 Rutin 0
.. 003 Fragrance 0.3
Water Residue Container Dish 11 Hair Rinse A hair rinse having the following composition was prepared.
製造法は常法によった。The manufacturing method was a conventional method.
ジプロピレングリコール 4. 0ステア
リルトリメチル
アンモニウムクロライド 2.0ステアリルア
ルコール 1.0ポリオキシエチレン(
60モル付加)
硬化ヒマシ油 0.5グリセリンス
テアリン酸エステル 0. 5ルチン
0.0005水 残余
夾嵐桝λ没 へアトニック
エチルアルコール55gにポリオキシエチレン(8モル
付加)オレイルアルコールエーテル2g及びルチン0.
00001g、香料を適量加え、室温下に溶解させてア
ルコール相を得た。別に精製水3.7.99999gに
グリセリン5gを加えて溶解させた。冷却後、色素を適
量加え、この水相部にアルコール相を加えて可溶化して
ふけ防止効果のあるヘアトニックを得た。Dipropylene glycol 4. 0 Stearyltrimethylammonium chloride 2.0 Stearyl alcohol 1.0 Polyoxyethylene (
60 mole addition) Hydrogenated castor oil 0.5 Glycerin stearate 0. 5 Rutin
0.0005 water Residue: 55 g of atonic ethyl alcohol, 2 g of polyoxyethylene (8 moles added), oleyl alcohol ether, and 0.00 rutin.
00001 g and an appropriate amount of fragrance were added and dissolved at room temperature to obtain an alcohol phase. Separately, 5 g of glycerin was added and dissolved in 3.7.99999 g of purified water. After cooling, an appropriate amount of the dye was added, and an alcohol phase was added to the aqueous phase to solubilize it to obtain a hair tonic with an anti-dandruff effect.
夾り皿lユ ヘアリキッド
エチルアルコール52.5gにポリオキシプロピレンブ
チルエーテル20g1スクワラン2g1ルチンO,00
05g及び香料を適量加え室温下に溶解させたアルコー
ル相に、精製水25.4995gに色素を適量加えた分
を添加し攪拌して、ふけ抑制効果のあるヘアリキッドを
得た。Hair liquid ethyl alcohol 52.5g, polyoxypropylene butyl ether 20g1 squalane 2g1 rutin O.00
25.4995 g of purified water and an appropriate amount of pigment were added to an alcohol phase in which an appropriate amount of 0.05 g and fragrance were added and dissolved at room temperature, and the mixture was stirred to obtain a hair liquid having a dandruff suppressing effect.
夾胤皿lユ 頭皮用乳液 ステアリン酸2g1セチルアルコール1.5g。Scalp emulsion 2g stearic acid 1.5g cetyl alcohol.
ワセリン3g1流動パラフイン12g1ポリオキシエチ
レン(10モル付加)モノオレイン酸エステルLg、ル
チンO,0008g、及び香料適量を混合し80℃に加
熱し油相を得た。別にプロピレングリコール5g1 ト
リエタノールアミン1g1及び精製水73.4992g
を80℃に加熱して、前記油相部を攪拌しながら徐々に
加え、冷却してふけ防止効果のある頭皮用乳液を得た。3 g of petrolatum, 12 g of liquid paraffin, 1 g of polyoxyethylene (10 mol addition), monooleate Lg, 0008 g of rutin O, and an appropriate amount of perfume were mixed and heated to 80° C. to obtain an oil phase. Separately, 5 g of propylene glycol, 1 g of triethanolamine, and 73.4992 g of purified water.
was heated to 80° C., the oil phase was gradually added while stirring, and the mixture was cooled to obtain a scalp emulsion having an anti-dandruff effect.
夾族週11 ヘアクリーム
ステアリン酸2g1ステアリルアルコール7g1オクチ
ルドデカノール6g1ポリオキシエチレン(10モル付
加)セチルエーテル3g1ルチン0゜02g及び香料を
適量加えて80℃に加熱して油相を得た。別にプロピレ
ングリコール5g1及び精製水76.98gを80℃に
加熱し、この水相に前記油相部を攪拌しつつ徐々に加え
、冷却してふけ抑制効果のあるヘアクリームを得た。11 Hair cream stearic acid 2g1 stearyl alcohol 7g1 octyldodecanol 6g1 polyoxyethylene (10 mol addition) cetyl ether 3g1 rutin 0.02g and an appropriate amount of fragrance were added and heated to 80°C to obtain an oil phase. Separately, 5 g of propylene glycol and 76.98 g of purified water were heated to 80° C., and the oil phase was gradually added to the aqueous phase with stirring, and the mixture was cooled to obtain a hair cream having a dandruff suppressing effect.
夫旧週24 頭髪用乳液 ポリエチレングリコール1500 3.5g。Husband's Week 24 Hair Emulsion Polyethylene glycol 1500 3.5g.
トリエタノールアミン1gを精製水74.4999gに
加温溶解し70℃に保った。ステアリン酸2.5g、セ
チルアルコール1.5g、ワセリン5g1スクワラン1
0g1ポリオキシエチレン(10モル付加)モノオレイ
ン酸エステル2g1ルチンO,0001gを加温溶解し
、70℃に保ち水相部に加えた。予備乳化後、ホモミキ
サーで均一に乳化し徐冷してふけ防止効果のある頭髪用
乳液を調製した。1 g of triethanolamine was dissolved in 74.4999 g of purified water by heating and maintained at 70°C. 2.5g stearic acid, 1.5g cetyl alcohol, 5g petrolatum, 11 squalane
0 g of polyoxyethylene (10 mol addition) monooleic acid ester 2 g and 10001 g of rutin O were dissolved by heating, and the mixture was kept at 70° C. and added to the aqueous phase. After preliminary emulsification, the mixture was uniformly emulsified using a homomixer and slowly cooled to prepare a hair emulsion with anti-dandruff effect.
[発明の効果]
本発明は以上説明したように構成されているので、以下
に記載されるような効果を奏する。[Effects of the Invention] Since the present invention is configured as described above, it produces the effects described below.
請求項1または2記載のふけ防止剤ないし頭髪化粧料に
よれば、尿酸及びその誘導体を含むこととしたので、安
全性、安定性が良好で、しかもふけ防止効果に優れてい
る。According to the anti-dandruff agent or hair cosmetic according to claim 1 or 2, since it contains uric acid and its derivatives, it is safe and stable and has an excellent anti-dandruff effect.
請求項3または4記載のふけ防止剤ないし頭髪化粧料に
よれば、ベタイン類及びそれらの塩を含むこととしたの
で、安全性、安定性が良好で、しかもふけ防止効果に優
れている。According to the anti-dandruff agent or hair cosmetic according to claim 3 or 4, since it contains betaines and their salts, it is safe and stable, and has an excellent anti-dandruff effect.
請求項5または6記載のふけ防止剤ないし頭髪化粧料に
よれば、ルチンを含むこととしたので、安全性、安定性
が良好で、しかも配合量が極めて微量であってもふけ防
止効果に優れている。According to the anti-dandruff agent or hair cosmetic according to claim 5 or 6, since it contains rutin, it has good safety and stability, and has an excellent anti-dandruff effect even when the amount is extremely small. ing.
Claims (6)
または二種以上の化合物を含むことを特徴とするふけ防
止剤。(1) An anti-dandruff agent characterized by containing one or more compounds selected from the group consisting of uric acid and its derivatives.
または二種以上の化合物を含むことを特徴とする頭髪化
粧料。(2) A hair cosmetic containing one or more compounds selected from the group consisting of uric acid and its derivatives.
た一種または二種以上の化合物を含むことを特徴とする
ふけ防止剤。(3) An anti-dandruff agent containing one or more compounds selected from the group consisting of betaines and their salts.
た一種または二種以上の化合物を含むことを特徴とする
頭髪化粧料。(4) A hair cosmetic containing one or more compounds selected from the group consisting of betaines and their salts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63103480A JP2696523B2 (en) | 1988-04-26 | 1988-04-26 | Anti-dandruff agent and hair cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63103480A JP2696523B2 (en) | 1988-04-26 | 1988-04-26 | Anti-dandruff agent and hair cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01275516A true JPH01275516A (en) | 1989-11-06 |
JP2696523B2 JP2696523B2 (en) | 1998-01-14 |
Family
ID=14355173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63103480A Expired - Lifetime JP2696523B2 (en) | 1988-04-26 | 1988-04-26 | Anti-dandruff agent and hair cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2696523B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011983A1 (en) * | 1990-02-13 | 1991-08-22 | Taisho Pharmaceutical Co., Ltd. | Novel use of alkanamidocarboxybetaine |
FR2740679A1 (en) * | 1995-11-03 | 1997-05-09 | Letourneur Raymond | New shampoo composition comprising rainwater |
EP0875241A2 (en) * | 1997-04-28 | 1998-11-04 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition |
US5833969A (en) * | 1997-06-25 | 1998-11-10 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and amphoteric surfactant and method for stably solubilizing uric acid in aqueous cosmetic composition |
DE102004013798A1 (en) * | 2004-03-20 | 2005-10-06 | Wella Aktiengesellschaft | Use of agents for the cosmetic treatment of keratin-containing material |
JP2011512397A (en) * | 2008-02-22 | 2011-04-21 | セダーマ | Moisturizing cosmetic composition comprising a combination of homarin and erythritol |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61238717A (en) * | 1985-04-17 | 1986-10-24 | Shiseido Co Ltd | Hair cosmetic |
JPS61289020A (en) * | 1985-06-14 | 1986-12-19 | Riken Vitamin Co Ltd | Hairdressing |
JPS62298566A (en) * | 1986-06-04 | 1987-12-25 | シグマ―タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | D(+)-carnitine alkylamide |
-
1988
- 1988-04-26 JP JP63103480A patent/JP2696523B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61238717A (en) * | 1985-04-17 | 1986-10-24 | Shiseido Co Ltd | Hair cosmetic |
JPS61289020A (en) * | 1985-06-14 | 1986-12-19 | Riken Vitamin Co Ltd | Hairdressing |
JPS62298566A (en) * | 1986-06-04 | 1987-12-25 | シグマ―タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | D(+)-carnitine alkylamide |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011983A1 (en) * | 1990-02-13 | 1991-08-22 | Taisho Pharmaceutical Co., Ltd. | Novel use of alkanamidocarboxybetaine |
FR2740679A1 (en) * | 1995-11-03 | 1997-05-09 | Letourneur Raymond | New shampoo composition comprising rainwater |
EP0875241A2 (en) * | 1997-04-28 | 1998-11-04 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition |
EP0875241A3 (en) * | 1997-04-28 | 1999-03-24 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition |
US6027719A (en) * | 1997-04-28 | 2000-02-22 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition |
US5833969A (en) * | 1997-06-25 | 1998-11-10 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and amphoteric surfactant and method for stably solubilizing uric acid in aqueous cosmetic composition |
EP0987009A1 (en) * | 1997-06-25 | 2000-03-22 | Yamahatsu Sangyo Kaisha, Ltd. | Aqueous cosmetic composition containing stably solubilized uric acid and amphoteric surfactant and method for stably solubilizing uric acid in aqueous cosmetic composition |
DE102004013798A1 (en) * | 2004-03-20 | 2005-10-06 | Wella Aktiengesellschaft | Use of agents for the cosmetic treatment of keratin-containing material |
JP2007529438A (en) * | 2004-03-20 | 2007-10-25 | ウエラ アクチェンゲゼルシャフト | Use of formulations for cosmetic treatment of keratin-containing materials |
JP2011512397A (en) * | 2008-02-22 | 2011-04-21 | セダーマ | Moisturizing cosmetic composition comprising a combination of homarin and erythritol |
Also Published As
Publication number | Publication date |
---|---|
JP2696523B2 (en) | 1998-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0582362B2 (en) | ||
JP2002193755A (en) | Antidandruff and anti-itching hair cosmetic and hair- shampooing cosmetic | |
KR100616342B1 (en) | Hair tonic composition | |
JPH01275516A (en) | Dandruff-preventive agent and hair-cosmetic | |
JPS6253917A (en) | Hair cosmetic | |
JPH0899889A (en) | Therapeutic agent for atopic dermatitis | |
US4728667A (en) | Hair treatment composition for prevention of dandruff in hair | |
WO1990015588A1 (en) | Hair growth stimulant | |
JPS61238716A (en) | Hair cosmetic | |
JPH02145507A (en) | Dandruff preventing cosmetic | |
JPS61238718A (en) | Hair cosmetic | |
JPH11302147A (en) | Cosmetic | |
JPS61238715A (en) | Hair cosmetic | |
JPS62153211A (en) | Hair cosmetic | |
JPS61210021A (en) | Hair cosmetic | |
JPS61197508A (en) | Hair cosmetic for preventing dandruff | |
JPH02145508A (en) | Dandruff-preventing cosmetic | |
JPS63198611A (en) | Hair cosmetic | |
JPS62169717A (en) | Hair cosmetic | |
JP2807792B2 (en) | External preparation for skin | |
JPS63119413A (en) | Hair cosmetic | |
JPS6360935A (en) | Sebum suppressive agent | |
JP2696523C (en) | ||
JPS61282309A (en) | Hair cosmetic | |
JPH07149614A (en) | Hair tonic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080919 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080919 Year of fee payment: 11 |